Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study.

Autor: Mashau RC; Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa. Electronic address: rudzanim@nicd.ac.za., Meiring ST; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Quan VC; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa., Nel J; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Infectious Diseases, Department of Medicine, Helen Joseph Hospital, Johannesburg, South Africa., Greene GS; Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa., Garcia A; Clinton Health Access Initiative, Pretoria, South Africa., Menezes C; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Reddy DL; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Venter M; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Division of Infectious Diseases, Department of Internal Medicine, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Stacey S; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa., Madua M; Department of Medicine, Rob Ferreira Hospital, Mbombela, South Africa., Boretti L; Division of Infectious Diseases and HIV Medicine, Livingstone Hospital, Gqeberha, South Africa., Harrison TS; Institute of Infection and Immunity, St George's University of London, London, UK; Clinical Academic Group in Infection and Immunity, St George's University Hospitals NHS Foundation Trust, London, UK; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK., Meintjes G; Department of Medicine, Wellcome Centre for Infectious Diseases Research in Africa and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Shroufi A; Medecins Sans Frontieres/Doctors Without Borders, Johannesburg, South Africa., Trivino-Duran L; Medecins Sans Frontieres/Doctors Without Borders, Johannesburg, South Africa., Black J; Division of Infectious Diseases and HIV Medicine, Livingstone Hospital, Gqeberha, South Africa., Govender NP; Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Institute of Infection and Immunity, St George's University of London, London, UK; MRC Centre for Medical Mycology, University of Exeter, Exeter, UK; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Sep; Vol. 22 (9), pp. 1365-1373. Date of Electronic Publication: 2022 Jun 21.

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.

Autor: Rajasingham R; Division of Infectious Diseases & International Medicine, University of Minnesota, Minnesota, United States of America., Meya DB; Infectious Diseases Institute, Makerere University, Kampala, Uganda., Greene GS; Mycotic Diseases Branch, Centers for Disease Control, Atlanta, Georgia, United States of America., Jordan A; Mycotic Diseases Branch, Centers for Disease Control, Atlanta, Georgia, United States of America., Nakawuka M; AIDS Control Program, Ministry of Health, Kampala, Uganda., Chiller TM; Mycotic Diseases Branch, Centers for Disease Control, Atlanta, Georgia, United States of America., Boulware DR; Division of Infectious Diseases & International Medicine, University of Minnesota, Minnesota, United States of America., Larson BA; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America.

Publikováno v: PloS one [PLoS One] 2019 Jan 10; Vol. 14 (1), pp. e0210105. Date of Electronic Publication: 2019 Jan 10 (Print Publication: 2019).

Cryptococcal meningitis: A neglected NTD?

Autor: Molloy SF; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom., Chiller T; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Greene GS; Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Burry J; Medecins Sans Frontières Access Campaign, Médecins Sans Frontières, Geneva, Switzerland., Govender NP; National Institute for Communicable Diseases (Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses), Johannesburg, South Africa.; Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Kanyama C; University of North Carolina Project, Lilongwe, Malawi., Mfinanga S; National Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania., Lesikari S; National Institute of Medial Research, Muhimbili Medical Research Centre, Dar Es Salaam, Tanzania., Mapoure YN; Central Hospital, Yaoundé, Cameroon., Kouanfack C; Department of Internal Medicine, Douala General Hospital, Douala, Cameroon., Sini V; Department of Internal Medicine, Douala General Hospital, Douala, Cameroon., Temfack E; Central Hospital, Yaoundé, Cameroon., Boulware DR; Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America., Dromer F; Institut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France., Denning DW; Global Action Fund for Fungal Infections (GAFFI), Geneva, Switzerland., Day J; Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam.; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Stone NRH; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom., Bicanic T; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom., Jarvis JN; Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Lortholary O; Institut Pasteur, Molecular Mycology-CNRS URA3012, Department of Mycology, Paris, France., Harrison TS; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom., Jaffar S; Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Loyse A; Centre for Global Health, Institute for Infection and Immunity, St George's, University of London, London, United Kingdom.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2017 Jun 29; Vol. 11 (6), pp. e0005575. Date of Electronic Publication: 2017 Jun 29 (Print Publication: 2017).

Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.

Autor: Minja, Makyao¹ (AUTHOR), Mbilinyi, Tusaligwe² (AUTHOR), Mkinga, Bryceson³ (AUTHOR), Philipo, Erick G.⁴ (AUTHOR), Owenya, Joyce⁵ (AUTHOR), Kilonzi, Manase¹ (AUTHOR) manasekilonzi@gmail.com

Publikováno v: PLoS ONE. 2/27/2024, Vol. 19 Issue 2, p1-11. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.